Results 51 to 60 of about 918 (92)

Radiosensitization of NET cells by HSP90 inhibitor ganetespib is mediated through pleiotropic stress responses. [PDF]

EJNMMI Res
Engbers PAM, Reuvers TGA, Heredia-Genestar JM, Chang J, Verkaik NS, Sabatella M, Nonnekens J.   +6 more
europepmc   +1 more source

Theranostic Radiopharmaceuticals of Somatostatin Receptors for Patients with Neuroendocrine Tumors: Agonists Versus Antagonists-A Systematic Review and Meta-Analysis. [PDF]

Int J Mol Sci
Wang Q, Librizzi D, Bagheri S, Ebrahimifard A, Hojjat Shamami A, Rinke A, Eilsberger F, Luster M, Hooshyar Yousefi B.   +8 more
europepmc   +1 more source

Limitations of the radiotheranostic concept in neuroendocrine tumors due to lineage-dependent somatostatin receptor expression on hematopoietic stem and progenitor cells. [PDF]

Theranostics
Nguyen N, Min Y, Rivière J, van der Garde M, Ghosh S, Bartos LM, Brendel M, Bassermann F, Azhdarinia A, Weber WA, Götze KS, Kossatz S.   +11 more
europepmc   +1 more source

Improving GRPR-targeting peptides for radiotheranostics application: insights from chelator modifications and α-methyl-L tryptophan substitution. [PDF]

EJNMMI Radiopharm Chem
Obeid K, Bezverkhniaia E, Tolmachev V, Orlova A, Kanellopoulos P.   +4 more
europepmc   +1 more source

Anatomical-biochemical discordance and prognostic role of bone metastases in advanced MTC treated with [¹⁷⁷Lu]Lu-DOTA-TATE. [PDF]

BMC Cancer
Bilgic S, Nazari A, Sağer MS, Sonmezoglu K.   +3 more
europepmc   +1 more source

Effects of Targeted Radionuclide Therapy on Cancer Cells Beyond the Ablative Radiation Dose. [PDF]

Int J Mol Sci
Ferro-Flores G, Azorín-Vega E, Ocampo-García B, Luna-Gutiérrez M, Cruz-Nova P, Meléndez-Alafort L.   +5 more
europepmc   +1 more source

Highlight selection of radiochemistry and radiopharmacy developments by editorial board. [PDF]

EJNMMI Radiopharm Chem
Toyohara J, Elsinga PH, Todde S, Li XG, Aime S, Szymanski WC, van der Meulen N, Cleeren F, Schirrmacher R, Yang H, Savio E, Bentaleb N, Zubillaga M, Chaple Gore IF, Bourgeois M, Mukherjee A, Pellico J, Kopka K.   +17 more
europepmc   +1 more source

Prognostic implications of [¹⁸F]FDG PET and metabolic changes in patients with advanced metastatic neuroendocrine tumors undergoing rechallenge PRRT: final results from a multicenter 10-year survival WARMTH study. [PDF]

Theranostics
Santo G, Rodrigues M, Paez D, Morozova O, Kabasakal L, Kairemo K, Grana CM, Baum RP, di Santo G, Virgolini IJ.   +9 more
europepmc   +1 more source

Contemporary opportunities and potential of Auger electron-emitting theranostics. [PDF]

Theranostics
Lee SY, Manning HC.
europepmc   +1 more source